High systolic blood pressure in adolescence is tied to a significantly higher risk of developing coronary atherosclerosis ...

November 20, 2025 | Ami Bhatt speaks with Tim Ryan about heart valve technology and the development of the Melody valve.

Ami Bhatt, Jenny Zablah, and Gareth Morgan discuss new advanced imaging approaches for treating congenital heart disease.

The UK Biobank study suggests depression and inflammation may mediate some of the association, but clinical trials are needed ...

Some question if patients want this information, but others say this tool can put risk into context and prompt lifestyle ...

The META-AF trial found fewer recurrences of atrial arrhythmias, a benefit unexplained by weight loss or glycemic control.

The PFA-SHAM trial and MANIFEST-US registry support the efficacy and safety of the increasingly used ablation modality.

EchoPrime was trained on more than 12 million videos; it’s now being tested clinically, with more data expected next year.

Quantifying blood flow instead of relying on angiography alone led to a change in diagnosis for 53% of patients.

The combination therapy improved LVEF, quality of life, clinical outcomes, and more, but implementation questions remain.

There was an increase in the hepatic fat fraction, the long-term consequences of which are unknown, says Robert Rosenson.

In TUXEDO-2, ticagrelor failed to meet the bar for noninferiority, with most outcomes hinting at an advantage for prasugrel.